GLO Dutch Bidco / Mallinckrodt Netherlands and Mallinckrodt Nuclear Medicine merger inquiry

The CMA investigated and cleared the completed acquisition by GLO Dutch Bidco of Mallinckrodt Netherlands Holdings BV and Mallinckrodt Nuclear Medicine LLC.

• From: Competition and Markets Authority
• Published: 30 March 2017
• Last updated: 7 July 2017 — See all updates

• Case type: Mergers
• Case state: Closed
• Market sector: Healthcare and medical equipment
• Outcome: Mergers - phase 1 clearance
• Opened: 30 March 2017
• Closed: 7 July 2017

Statutory timetable

Phase 1 Date	Action
7 July 2017	Decision published
26 June 2017	Decision announced
5 June 2017	Revocation of the initial enforcement order
8 May 2017	Launch of merger inquiry
24 March 2017	Initial enforcement order

Phase 1

CMA clearance decision

26 June 2017: The CMA has cleared the acquisition by GLO Dutch Bidco of Mallinckrodt Netherlands Holdings BV and Mallinckrodt Nuclear Medicine LLC, using the ‘de minimis’ exception. The full text of the decision is available below.

• Full text decision (7.7.17)
• News story: CMA applies discretion not to refer IBA/Mallinckrodt merger (26.6.17)

Revocation of initial enforcement order

7 June 2017: In view of the evidence available to the CMA at this stage, the CMA revoked the initial enforcement order on 5 June 2017.

• Revocation order (7.6.17)

Launch of merger inquiry

8 May 2017: The CMA announced the launch of its merger inquiry by notice to the parties.

• Commencement of initial period notice (8.5.17)

Initial enforcement order

31 March 2017: On 24 March 2017, the CMA served an initial enforcement order under section 72(2) of the Enterprise Act 2002 on GLO BidCo S.ả r.l., IBA Pharma SA, GLO Dutch Bidco, B.V. and Mallinckrodt Netherlands Holdings BV, in relation to the completed acquisition GLO Dutch Bidco B.V. of Mallinckrodt Netherlands Holdings B.V. and Mallinckrodt Nuclear Medicine LLC.

• Variation order (12.4.17)
• Initial enforcement order (31.3.17)

Amendments/consents granted

• Derogation 11 May 2017 (12.5.17)
• Derogation 28 March 2017 (31.3.17)
• Derogation 30 March 2017 (31.3.17)

Contact

Please send written representations about any competition or public interest to:

[email protected]

Published 30 March 2017
Last updated 7 July 2017 + show all updates

1. 7 July 2017

   Full text of the decision published.

2. 26 June 2017

   Clearance decision announced.

3. 7 June 2017

   Revocation order published.

4. 12 May 2017

   Derogation published.

5. 8 May 2017

   Launch of CMA merger inquiry

6. 12 April 2017

   Variation order published.

7. 31 March 2017

   Initial enforcement order and derogations published.

8. 30 March 2017

   First published.